Cite
HARVARD Citation
Hong, N. et al. (n.d.). Advances in the development of a targeted N-Terminal Domain androgen receptor (AR) degrader (ANITAC) for the treatment of prostate cancer. European journal of cancer. pp. S37-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hong, N. et al. (n.d.). Advances in the development of a targeted N-Terminal Domain androgen receptor (AR) degrader (ANITAC) for the treatment of prostate cancer. European journal of cancer. pp. S37-. [Online].